Filing Details
- Accession Number:
- 0000899243-21-000897
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-01-07 16:33:35
- Reporting Period:
- 2021-01-05
- Accepted Time:
- 2021-01-07 16:33:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1440132 | S Joel Goldberg | 940 Winter Street Waltham MA 02451 | Please See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-01-05 | 1,158 | $46.26 | 73,293 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-01-05 | 39 | $152.50 | 73,254 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-05 | 1,479 | $152.51 | 71,775 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2021-01-06 | 25,149 | $46.26 | 96,924 | No | 4 | M | Direct | |
Common Stock | Disposition | 2021-01-06 | 700 | $153.06 | 96,224 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-06 | 900 | $154.04 | 95,324 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-06 | 12,211 | $155.20 | 83,113 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-06 | 9,938 | $155.98 | 73,175 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-06 | 1,000 | $157.00 | 72,175 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-01-06 | 400 | $157.82 | 71,775 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | NQ Stock Option (right to buy) | Disposition | 2021-01-05 | 1,518 | $0.00 | 1,518 | $46.26 |
Common Stock | NQ Stock Option (right to buy) | Disposition | 2021-01-06 | 25,149 | $0.00 | 25,149 | $46.26 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
25,149 | 2022-02-03 | No | 4 | M | Direct | |
0 | 2022-02-03 | No | 4 | M | Direct |
Footnotes
- The Exercise Price included on the Form 4 filed on February 4, 2015 for the Reporting Person was incorrectly reported due to administrative error.
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Goldberg on November 13, 2020.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $152.50 to $153.42. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $153.59 to $154.47. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $154.64 to $155.63. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $155.64 to $156.53. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $156.66 to $157.50. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $157.72 to $157.98. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three equal annual installments beginning on February 3, 2016, which was the first anniversary of the date on which the option was granted.